Search research articles
Contact Us
Filters
Showing results (21-30 of 141) with videos related to
Page
of 15
Sort By:
BMC Health Services Research
|
September 1, 2017
Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes
Liz Morrell, Sarah Wordsworth, Howell Fu, et al.
Plos One
|
December 19, 2017
The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgery
Jilles M Fermont, Jane M Blazeby, Chris A Rogers, et al.
Current Medical Research and Opinion
|
February 13, 2009
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison
Steven J Edwards, Mike J Clarke, Sarah Wordsworth, et al.
Health Economics
|
November 17, 2021
Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets
John Buckell, Vrinda Vasavada, Sarah Wordsworth, et al.
International Journal of Technology Assessment in Health Care
|
March 2, 2005
Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options
Juan G Gonzalez-Perez, Luke Vale, Sally C Stearns, et al.
Journal of Clinical Epidemiology
|
July 8, 2014
Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence
Jose Leal, Sarah Wordsworth, Juliet Oerton, et al.
Pharmacoeconomics
|
August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK
Liz Morrell, James Buchanan, Sian Rees, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions
Dean A Regier, Deirdre Weymann, James Buchanan, et al.
European Journal of Human Genetics : EJHG
|
June 1, 2026
The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review
Frederick McElwee, Sally L Sansom, James Buchanan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 16, 2022
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Padraig Dixon, Edna Keeney, Jenny C Taylor, et al.
Page
of 15
Search research articles
Search
Showing results (21-30 of 141) with videos related to
Sort By:
Page
of 15
BMC Health Services Research
|
September 1, 2017
Cancer drug funding decisions in Scotland: impact of new end-of-life, orphan and ultra-orphan processes
Liz Morrell, Sarah Wordsworth, Howell Fu, et al.
Plos One
|
December 19, 2017
The EQ-5D-5L is a valid approach to measure health related quality of life in patients undergoing bariatric surgery
Jilles M Fermont, Jane M Blazeby, Chris A Rogers, et al.
Current Medical Research and Opinion
|
February 13, 2009
Carbapenems versus other beta-lactams in the treatment of hospitalised patients with infection: a mixed treatment comparison
Steven J Edwards, Mike J Clarke, Sarah Wordsworth, et al.
Health Economics
|
November 17, 2021
Utility maximization versus regret minimization in health choice behavior: Evidence from four datasets
John Buckell, Vrinda Vasavada, Sarah Wordsworth, et al.
International Journal of Technology Assessment in Health Care
|
March 2, 2005
Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options
Juan G Gonzalez-Perez, Luke Vale, Sally C Stearns, et al.
Journal of Clinical Epidemiology
|
July 8, 2014
Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence
Jose Leal, Sarah Wordsworth, Juliet Oerton, et al.
Pharmacoeconomics
|
August 19, 2021
What Aspects of Illness Influence Public Preferences for Healthcare Priority Setting? A Discrete Choice Experiment in the UK
Liz Morrell, James Buchanan, Sian Rees, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 19, 2018
Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions
Dean A Regier, Deirdre Weymann, James Buchanan, et al.
European Journal of Human Genetics : EJHG
|
June 1, 2026
The cost and cost-effectiveness of whole-exome and whole-genome sequencing: a systematic literature review
Frederick McElwee, Sally L Sansom, James Buchanan, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 16, 2022
Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review
Padraig Dixon, Edna Keeney, Jenny C Taylor, et al.
Page
of 15